{"a":[{"_":"Galderma, Novartis dominated ad space last NFL season with most effective ads: report ","$":{"href":"/marketing/galderma-novartis-dominated-ad-space-during-last-nfl-season-most-effective-ads-report","hreflang":"en"}}]}

Summary

Galderma's skin disease medication Nemluvio achieved the highest engagement score among all advertisers during the 2025-26 NFL season, according to analysis by TV outcomes company EDO, demonstrating strong marketing performance for both Galderma and parent company Novartis.